Financial Toxicity Considerations in Breast Reconstruction: Recommendations for Research and Practice
- 26 February 2024
- journal article
- research article
- Published by Elsevier in Women's Health Issues
- Vol. 34 (2) , 107-114
Abstract
No abstract availableKeywords
Funding Information
- Agency for Healthcare Research and Quality
- Foundation for Barnes-Jewish Hospital
- Siteman Cancer Center
This publication has 69 references indexed in Scilit:
- Commercial Price Variation for Breast Reconstruction in the Era of Price TransparencyJAMA Surgery, 2023
- Perceived financial decline related to breast reconstruction following mastectomy in a diverse population‐based cohortCancer, 2021
- Costs of cancer along the care continuum: What we can expect based on recent literatureCancer, 2018
- Comparison of 2-Year Complication Rates Among Common Techniques for Postmastectomy Breast ReconstructionJAMA Surgery, 2018
- Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancerCancer, 2018
- Treatment decisions and employment of breast cancer patients: Results of a population‐based surveyCancer, 2017
- Economic hardship of minority and non‐minority cancer survivors 1 year after diagnosis: Another long‐term effect of cancer?Cancer, 2015
- Access to Breast Reconstruction After Mastectomy and Patient Perspectives on Reconstruction Decision MakingJAMA Surgery, 2014
- Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care?Cancer, 2013
- Cancer Survivors and UnemploymentJAMA, 2009